Song J, Guo WY, Sun LB. Qige San regulates paclitaxel resistance in esophageal cancer by targeting ferroptosis. World J Gastrointest Oncol 2025; 17(8): 106783 [PMID: 40837755 DOI: 10.4251/wjgo.v17.i8.106783]
Corresponding Author of This Article
Le-Bo Sun, Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital of Ningbo University, No. 57 Xingning Road, Ningbo 315041, Zhejiang Province, China. sunlebo0910@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Aug 15, 2025 (publication date) through Nov 20, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Song J, Guo WY, Sun LB. Qige San regulates paclitaxel resistance in esophageal cancer by targeting ferroptosis. World J Gastrointest Oncol 2025; 17(8): 106783 [PMID: 40837755 DOI: 10.4251/wjgo.v17.i8.106783]
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 106783 Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106783
Qige San regulates paclitaxel resistance in esophageal cancer by targeting ferroptosis
Jie Song, Wen-Ying Guo, Le-Bo Sun
Jie Song, Le-Bo Sun, Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital of Ningbo University, Ningbo 315041, Zhejiang Province, China
Wen-Ying Guo, Department of Gastroenterology, Ningbo Medical Center Lihuili Hospital, Ningbo 315000, Zhejiang Province, China
Author contributions: Song J designed the research study; Guo WY performed the research; Sun LB conducted experiments and analyzed the data; All authors contributed to editorial changes in the manuscript and read and approved the final manuscript.
Supported by Zhejiang Traditional Chinese Medicine Administration, No. 2024ZL944.
Institutional review board statement: This study was approved by the Ethics Committee of Ningbo Medical Center Lihuili Hospital of Ningbo University, No. LHL159329.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Le-Bo Sun, Department of Cardiothoracic Surgery, Ningbo Medical Center Lihuili Hospital of Ningbo University, No. 57 Xingning Road, Ningbo 315041, Zhejiang Province, China. sunlebo0910@163.com
Received: April 18, 2025 Revised: May 14, 2025 Accepted: July 7, 2025 Published online: August 15, 2025 Processing time: 117 Days and 21.2 Hours
Abstract
BACKGROUND
Abnormal iron metabolism plays a critical role in paclitaxel (PTX) resistance in esophageal cancer cells. Qige San (QG) is a traditional Chinese herbal formula that is reported to improve short-term therapeutic effects of esophageal cancer.
AIM
To investigate the effects and regulatory mechanisms involved in QG-targeted PTX-resistant esophageal cancer cells.
METHODS
Cell viability was assessed using the Cell Counting Kit-8 assay. Ferroptosis was evaluated by analyzing lipid reactive oxygen species accumulation and the Fe2+ concentration in PTX-resistant esophageal cancer cells. Expression of ferroptosis regulators was measured by western blot. Network pharmacology analysis was employed to identify potential targets of QG in PTX-resistant esophageal cancer cells.
RESULTS
Treatment with QG significantly suppressed the viability, proliferation, and migration of PTX-resistant esophageal cancer cells and simultaneously induced ferroptosis. The network pharmacology analysis identified the phosphoinositide 3-kinase (PI3K)/protein kinase B signaling pathway as the potential target of QG in PTX-resistant esophageal cancer cells. Activation of the PI3K pathway notably reversed the ferroptosis of PTX-resistant esophageal cancer cells that was induced by QG.
CONCLUSION
QG could repress the resistance of esophageal cancer cells to PTX via targeting the PI3K signaling pathway.
Core Tip: Abnormal iron metabolism plays a critical role in paclitaxel-resistance of esophageal cancer cells. Qige San (QG) is a traditional Chinese herbal formula that is reported to improve short-term therapeutic effects of esophageal cancer. We observed that QG could repress the resistance of esophageal cancer cells to paclitaxel via targeting the phosphoinositide 3-kinase/protein kinase B signaling pathway.
